Aurora Laborda-Illanes

A New Paradigm in the Relationship between Melatonin and Breast Cancer: Gut Microbiota Identified as a Potential Regulatory Agent

E. Alba, L. Sánchez-Alcoholado, M. Queipo-Ortuño, 2021, Cancers.

High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

E. Alba, C. D. de Andrea, M. Cobo, 2022, International journal of molecular sciences.

Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment

E. Alba, L. Sánchez-Alcoholado, M. Queipo-Ortuño, 2020, Cancers.

Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer

E. Alba, L. Sánchez-Alcoholado, M. Queipo-Ortuño, 2021, Journal of personalized medicine.

The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response

L. Sánchez-Alcoholado, M. Queipo-Ortuño, B. Ramos-Molina, 2020, Cancers.

Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer

L. Sánchez-Alcoholado, M. Queipo-Ortuño, B. Ramos-Molina, 2020, International journal of molecular sciences.

Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients

L. Sánchez-Alcoholado, M. Queipo-Ortuño, B. Ramos-Molina, 2021, International journal of molecular sciences.

Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.

E. Alba, L. Sánchez-Alcoholado, M. Queipo-Ortuño, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Connection between the Gut Microbiome, Systemic Inflammation, Gut Permeability and FOXP3 Expression in Patients with Primary Sjögren’s Syndrome

L. Sánchez-Alcoholado, M. Queipo-Ortuño, I. Leiva-Gea, 2020, International journal of molecular sciences.